Company Overview of Oxford GlycoSciences Plc
As of July 17, 2003, Oxford GlycoSciences Plc was acquired by Celltech Group plc. Oxford GlycoSciences Plc operates as a biopharmaceutical company applying proteomics technologies and glycobiology to the discovery, development, and commercialisation of novel therapeutic products. Its drug discovery efforts focus on three main therapeutic areas: cancer, anti-infective, and glycolipid storage disorders. The company is headquartered at Abingdon, United Kingdom with an additional office in Oxfordshire, United Kingdom.
86 Milton Park
Abingdon, OX14 4RY
44 12 3520 8020
Key Executives for Oxford GlycoSciences Plc
Oxford GlycoSciences Plc does not have any Key Executives recorded.
Similar Private Companies By Industry
|Abbey Pharma Limited||Europe|
|Absynth Biologics Limited||Europe|
|Acacia Pharma Limited||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|Bloomberg L.P.||United States|
Sponsored Financial Commentaries
To contact Oxford GlycoSciences Plc, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.